BRISTOL, Tenn., Jan. 4 /PRNewswire-FirstCall/ -- King Pharmaceuticals, Inc. will host a live webcast of its meeting with investors scheduled for Thursday, January 5, 2006, at 12:15 p.m., E.S.T. at the Morgan Stanley Pharmaceutical Conference at Morgan Stanley’s Corporate Headquarters in New York, New York. The Company expects topics of discussion to include the Company’s strategic plan for growth, an update on the status of ongoing development projects, and other matters pertaining to King’s business. Interested persons may access the webcast on the King Pharmaceuticals home page at http://www.kingpharm.com. After the event, a replay of the webcast may be accessed through Thursday, January 19, 2006 at the same URL.
King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products in attractive markets and the strategic acquisition of branded products that can benefit from focused promotion and marketing and product life-cycle management.
King Pharmaceuticals, Inc.
CONTACT: James E. Green, Executive Vice President, Corporate Affairs,+1-423-989-8125, or David E. Robinson, Sr. Director, Corporate Affairs,+1-423-989-7045, both of King Pharmaceuticals, Inc.
Web site: http://www.kingpharm.com/
Company News On-Call: http://www.prnewswire.com/comp/120319.html /
